{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:13:02Z","timestamp":1789776782700,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U24AI86837"],"award-info":[{"award-number":["U24AI86837"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002894","name":"American Academy of Allergy Asthma and Immunology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003011","name":"Immune Deficiency Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006021","name":"US Immunodeficiency Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23HD104933"],"award-info":[{"award-number":["1K23HD104933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jaip.2021.12.035","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T02:33:34Z","timestamp":1642127614000},"page":"1325-1333.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry"],"prefix":"10.1016","volume":"10","author":[{"given":"Brenna","family":"LaBere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Garabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsay L.","family":"Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.12.035_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(76)93021-X","article-title":"Characterisation of the enzyme defect in chronic granulomatous disease","volume":"1","author":"Segal","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.12.035_bib2","series-title":"GeneReviews\u00ae","article-title":"Chronic granulomatous disease","author":"Leiding","year":"1993"},{"key":"10.1016\/j.jaip.2021.12.035_bib3","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.035_bib4","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1038\/s41467-018-06964-x","article-title":"A\u00a0homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease","volume":"9","author":"Arnadottir","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2021.12.035_bib5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaci.2018.09.019","article-title":"EROS\/CYBC1 mutations: decreased NADPH oxidase function and chronic granulomatous disease","volume":"143","author":"Thomas","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2021.12.035_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.114.2.462","article-title":"Gastrointestinal involvement in chronic granulomatous disease","volume":"114","author":"Marciano","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.12.035_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/pai.12814","article-title":"Inflammatory bowel disease in chronic granulomatous disease: an emerging problem over a twenty years\u2019 experience","volume":"28","author":"Angelino","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib9","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1097\/MIB.0000000000000966","article-title":"Genetic risk for inflammatory bowel disease is a determinant of Crohn\u2019s disease development in chronic granulomatous disease","volume":"22","author":"Huang","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaip.2021.12.035_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ajg.2008.72","article-title":"Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn\u2019s disease","volume":"104","author":"Marks","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.12.035_bib11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/PAS.0b013e318297427d","article-title":"Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients","volume":"37","author":"Alimchandani","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2021.12.035_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cgh.2015.10.030","article-title":"Gastrointestinal features of chronic granulomatous disease found during endoscopy","volume":"14","author":"Khangura","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.12.035_bib13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/INF.0000000000001284","article-title":"Colitis as the sole initial presentation of chronic granulomatous disease: histopathologic clues to diagnosis","volume":"35","author":"Rosenbaum","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2021.12.035_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/adc.84.2.147","article-title":"Colitis in chronic granulomatous disease","volume":"84","author":"Schappi","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2021.12.035_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jaci.2010.01.035","article-title":"Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease","volume":"125","author":"Freudenberg","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ecco-jcc\/jjv186","article-title":"Diagnostic and treatment options for severe IBD in female X-CGD carriers with non-random X-inactivation","volume":"10","author":"Hauck","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.jaip.2021.12.035_bib17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.12.035_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaci.2011.04.028","article-title":"TNF-alpha blockade in chronic granulomatous disease-induced hyperinflammation: patient analysis and murine model","volume":"128","author":"Deffert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10875-018-0524-9","article-title":"The treatment of inflammatory bowel disease in patients with selected primary immunodeficiencies","volume":"38","author":"Shouval","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12185-011-0932-6","article-title":"Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection","volume":"94","author":"Kato","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaip.2021.12.035_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"Gungor","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.12.035_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10875-019-00659-8","article-title":"Chronic granulomatous disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT","volume":"39","author":"Marsh","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.12.035_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.24573","article-title":"Chronic granulomatous disease: clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients","volume":"92","author":"Wolach","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2021.12.035_bib25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s10875-014-0028-1","article-title":"USIDNET: a strategy to build a community of clinical immunologists","volume":"34","author":"Sullivan","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1067\/mpd.2000.109112","article-title":"Long-term follow-up and outcome of 39 patients with chronic granulomatous disease","volume":"137","author":"Liese","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.12.035_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","article-title":"Genetic, biochemical, and clinical features of chronic granulomatous disease","volume":"79","author":"Segal","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2021.12.035_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","article-title":"Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry","volume":"152","author":"Jones","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","article-title":"Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients","volume":"132","author":"Koker","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/INF.0000000000000840","article-title":"Chronic granulomatous disease: a large, single-center US experience","volume":"34","author":"Bortoletto","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2021.12.035_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2431-14-156","article-title":"Chronic granulomatous disease mimicking early-onset Crohn\u2019s disease with cutaneous manifestations","volume":"14","author":"Barbato","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jaip.2021.12.035_bib33","first-page":"498","article-title":"Chronic granulomatous disease mimicking Crohn\u2019s disease","volume":"4","author":"Isaacs","year":"1985","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.12.035_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/INF.0b013e3181f13b23","article-title":"Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France","volume":"30","author":"Beaute","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2021.12.035_bib35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.12.035_bib36","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/cir731","article-title":"Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey","volume":"53","author":"Blumental","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.12.035_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-99-5-657","article-title":"NIH conference. Recent advances in chronic granulomatous disease","volume":"99","author":"Gallin","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2021.12.035_bib38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","article-title":"Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease","volume":"162","author":"Margolis","year":"1990","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jaip.2021.12.035_bib39","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/jpids\/piy016","article-title":"Prevention of infectious complications in patients with chronic granulomatous disease","volume":"7","author":"Slack","year":"2018","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jaip.2021.12.035_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-016-8591-2","article-title":"An update on the use of immunomodulators in primary immunodeficiencies","volume":"52","author":"Vignesh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10875-016-0318-x","article-title":"Treatment of CGD-associated colitis with the IL-23 blocker ustekinumab","volume":"36","author":"Butte","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.035_bib42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1124\/jpet.109.153973","article-title":"The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases","volume":"330","author":"Soler","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jaip.2021.12.035_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/gastro\/goaa005","article-title":"The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease","volume":"8","author":"Kamal","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.jaip.2021.12.035_bib44","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans","volume":"111","author":"de Luca","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2021.12.035_bib45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/ajg.2015.135","article-title":"Treatment with anakinra, a recombinant IL-1 receptor antagonist, unlikely to Induce lasting remission in patients with CGD colitis","volume":"110","author":"Hahn","year":"2015","journal-title":"Am J Gastroenterol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:34:03Z","timestamp":1761975243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213219822000101"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.12.035","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}